跳至主要内容
临床试验/CTIS2023-506152-24-00
CTIS2023-506152-24-00招募中1 期

Goal-directed Fluid Therapy during deep inferior epigastric perforator (DIEP) free flap breast reconstruction – a randomized controlled trial

Az Maria Middelares Gent0 个研究点目标入组 82 人开始时间: 2023年6月29日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
82

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)

入选标准

  • Female adult patients, between 18 and 70 years of age, Patients scheduled for DIEP free flap breast reconstruction, Signed written informed consent form

排除标准

  • present atrial fibrillation (AF), heart failure New York Heart Association (NYHA) classification 2 or higher, chronic kidney disease (CKD) stage 3B or higher, American Society of Anesthesiologists (ASA) classification III or higher, known allergy to study specific medication, participation in another clinical trial, Patients who are pregnant or breastfeeding, Inability of the patient to understand Dutch sufficiently

研究者

发起方
Az Maria Middelares Gent

相似试验